Found: 16
Select item for more details and to access through your institution.
Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 920, doi. 10.3390/vaccines11050920
- By:
- Publication type:
- Article
Waning of Humoral Immunity and the Influencing Factors after BNT162b2 Vaccination: A Cohort Study with a Latent Growth Curve Model in Fukushima.
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 2007, doi. 10.3390/vaccines10122007
- By:
- Publication type:
- Article
Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040515
- By:
- Publication type:
- Article
Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36429-1
- By:
- Publication type:
- Article
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-21797-x
- By:
- Publication type:
- Article
A retrospective observational study analyzing work and study motivation based on the work environment of 15,677 Japanese clinicians in 2016.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-19007-9
- By:
- Publication type:
- Article
Time course of adverse reactions following BNT162b2 vaccination in healthy and allergic disease individuals aged 5–11 years and comparison with individuals aged 12–15 years: an observational and historical cohort study.
- Published in:
- European Journal of Pediatrics, 2023, v. 182, n. 1, p. 123, doi. 10.1007/s00431-022-04643-0
- By:
- Publication type:
- Article
Smoking cessation treatment by anesthesiologists.
- Published in:
- Journal of Anesthesia, 2023, v. 37, n. 2, p. 319, doi. 10.1007/s00540-022-03155-3
- By:
- Publication type:
- Article
Mental distress in a clinical nurse due to a false‐positive COVID‐19 antibody test result during the COVID‐19 epidemic in Japan: A case report.
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 5, p. 1, doi. 10.1002/ccr3.4122
- By:
- Publication type:
- Article
Age as a decisive factor in general anaesthesia use in paediatric proton beam therapy.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72223-z
- By:
- Publication type:
- Article
Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0269917
- By:
- Publication type:
- Article
Maturing of public-private-people partnership (4P): Lessons from 4P for triple disaster and subsequently COVID-19 pandemic in Fukushima.
- Published in:
- Journal of Global Health, 2022, v. 12, p. 1, doi. 10.7189/jogh.12.03028
- By:
- Publication type:
- Article
Importance of individualized disaster preparedness for hospitalized or institutionalized patients: Lessons learned from the legal revisions made to the Basic Act on Disaster Management in Japan following the Fhkushima nuclear disaster.
- Published in:
- Journal of Global Health, 2021, v. 11, p. 1, doi. 10.7189/jogh.11.03108
- By:
- Publication type:
- Article
The Nepalese health care system and challenges during COVID-19.
- Published in:
- Journal of Global Health, 2021, v. 11, p. 1, doi. 10.7189/jogh.11.03030
- By:
- Publication type:
- Article
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population.
- Published in:
- PLoS Digital Health, 2024, v. 3, n. 5, p. 1, doi. 10.1371/journal.pdig.0000497
- By:
- Publication type:
- Article
Peak IgG antibody titers against SARS-CoV-2 spike protein following immunization with the Pfizer/BioNTech BNT162b2 vaccine.
- Published in:
- Fukushima Journal of Medical Science, 2022, v. 68, n. 1, p. 67, doi. 10.5387/fms.2021-28
- By:
- Publication type:
- Article